MicroRNA-22 Impairs Anti-Tumor Ability of Dendritic Cells by Targeting p38

• Xue Liang ,

  Contributed equally to this work with: Xue Liang, Yu Liu

  Affiliations Department of Immunology, Nankai University School of Medicine, Tianjin, China, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China

  ⨯
• Yu Liu ,

  Contributed equally to this work with: Xue Liang, Yu Liu

  Affiliation Department of Immunology, Nankai University School of Medicine, Tianjin, China

  ⨯
• Shiyue Mei,

  Affiliation Department of Immunology, Nankai University School of Medicine, Tianjin, China

  ⨯
• Miaomiao Zhang,

  Affiliation Department of Immunology, Nankai University School of Medicine, Tianjin, China

  ⨯
• Jiaxuan Xin,

  Affiliation Department of Immunology, Nankai University School of Medicine, Tianjin, China

  ⨯
• Yuan Zhang,

  Affiliation Department of Immunology, Nankai University School of Medicine, Tianjin, China

  ⨯
• Rongcun Yang

  * E-mail: ryang@nankai.edu.cn

  Affiliations Department of Immunology, Nankai University School of Medicine, Tianjin, China, State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China, Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, Tianjin, China

  ⨯